Top Tweets for #StridesPharmaScience

Indian Pharma Post @indpharmapost

over 1 year ago

#StridesPharmaScience shares rise nearly 8%. #NDTVProfitStocks Read to know more ⬇️ https://t.co/YMBPHjrVWG

0

2

0

1

1K

CNBC-TV18

@CNBCTV18News

over 1 year ago

#StridesPharmaScience plans to list #OneSourceSpecialty Pharma shares in Q4 FY25 @jpullokaran https://t.co/1cZijQOLbi

0

3

0

3K

Raghav Wadhwa

@raghavwadhwa

over 1 year ago

💊Pharmaceutical Sector Stocks: #AartiPharmalabs #ShreeGaneshRemedies #StridesPharmaScience #MarksansPharma #NatcoPharma

raghavwadhwa's tweet photo. 💊Pharmaceutical Sector Stocks:
#AartiPharmalabs #ShreeGaneshRemedies #StridesPharmaScience #MarksansPharma #NatcoPharma https://t.co/YRgoTtPQZS

2

27

2

15

7K

over 1 year ago

Strides Pharma Science appoints Dr. C. Muthulingam as Executive VP - R&D https://t.co/Awd8VoCFuF #StridesPharmaScience #Dr.C.Muthulingam #MankindPharma #AurobindoPharma #AlembicLtd. #PiramalHealthcare #Ranbaxy #Dr.Reddy’s @indpharmapost

0

2

0

412

almost 2 years ago

Strides Pharma Science Ltd gets EIR from USFDA on continued GMP status for the facility in Alathur, Chennai #StridesPharmaScience #StridesAlathur #USFDA #EIR #GMPStatus #Chennai https://t.co/Uj5gUVyVdT

0

2

0

587

almost 2 years ago

#StridesPharmaScience shares rise to a nearly nine-year high. #NDTVProfitStocks Read more ⬇️ https://t.co/ZzqD91Uiv0

0

1K

ET Now Swadesh

@ETNowSwadesh

almost 2 years ago

#EarningsWithSwadesh | #STRIDESPHARMASCIENCE ने जारी किए जून तिमाही (Q1) के नतीजे (YoY) कंसो आय ₹930 Cr से बढ़कर ₹1087 Cr ₹9.3 Cr घाटे के मुकाबले ₹68.3 Cr का मुनाफा #Q1WithSwadesh #StockMarket #StocksToWatch

0

3

0

311

Anand Rathi Share and Stock Brokers Limited @rathi_online

over 2 years ago

#StridesPharmaScience approves investment in arms AMP Energy C&I Six (AMP-6) and AMP Energy C&I Eight (AMP-8). For the latest news and updates, visit: https://t.co/NKSVSeIu63

NDTVProfitIndia's tweet photo. #StridesPharmaScience approves investment in arms AMP Energy C&I Six (AMP-6) and AMP Energy C&I Eight (AMP-8).

For the latest news and updates, visit: https://t.co/NKSVSeIu63 https://t.co/C5bO4efp9J

0

7

1

0

3K

over 2 years ago

2. #StridesPharmaScience - #NetLoss 1.3B rupees vs 228M (YoY) - #Revenue 10B rupees vs 9B (YoY) - EBITDA #rupees 1.80B vs 1.69B (YoY) - #EBITDA margin 17.5% vs 18.1% (YoY)

1

0

52

almost 3 years ago

#StridesPharmaScience's subsidiary receives approval from U.S. health regulator to market generic version of #GileadSciences' #Atripla tablets. https://t.co/Xw5sdFWtL6

0

4

0

1K

almost 3 years ago

Strides receives USFDA approval for Icosapent Ethyl Capsules #StridesPharmaScience #USFDA #Approval #IcosapentEthylCapsules https://t.co/kB9rCkQriE

0

3

1

764

almost 3 years ago

Strides receives tentative USFDA approval for Dolutegravir tablets #StridesPharmaScience #USFDA #TentativeApproval #DolutegravirTablets https://t.co/uVpQf9s0oy

0

5

0

514

almost 3 years ago

Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension #StridesPharmaScience #USFDA #Approval https://t.co/75TUrN1rjd

0

3

0

632

almost 3 years ago

Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd #StridesPharmaScience #Acquisition https://t.co/vAFpie7rHC

0

2

0

472

almost 3 years ago

#StridesPharmaScience approves acquiring its step-down subsidiary Strides Pharma Services. For the latest news and updates, visit: https://t.co/gXeGqKQ77P

NDTVProfitIndia's tweet photo. #StridesPharmaScience approves acquiring its step-down subsidiary Strides Pharma Services.

For the latest news and updates, visit: https://t.co/gXeGqKQ77P https://t.co/giwW82p7Wb

0

3

0

1K